Amrinone or inamrinone

This classification denotes a vasodilating agent and phosphodiesterase inhibitor with the molecular formula C10H9N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier JUT23379TN, chemically known as 5-amino-(3,4-bipyridin)-6(1h)-one but generally known as amrinone, which bears US NIH Compound Identifier 3698. European Medicines Agency schedules Amrinone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05493MIG. The term AMRINONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18). World Health Organization schedules amrinone in its Anatomical Therapeutic Chemical (ATC) Classification. AMRINONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Amrinone or inamrinone bears US NLM identifiers UMLS ID C0002697 and NCI Concept Code C61789. SMILES: C1=CN=CC=C1C2=CNC(=O)C(=C2)N.